The Role of ATRX in Glioma Biology
- PMID: 29034211
- PMCID: PMC5626857
- DOI: 10.3389/fonc.2017.00236
The Role of ATRX in Glioma Biology
Abstract
The current World Health Organization classification of CNS tumors has made a tremendous leap from past editions by incorporating molecular criteria in addition to the pre-existing histological parameters. The revised version has had a particular impact on the classification of diffuse low-grade gliomas and their high-grade variants. The ATRX status is one of the critical markers that define the molecular classification of gliomas. In this review, we will first provide an overview of the role of ATRX in regular cell biology. Furthermore, the role of ATRX in tumorigenesis, specifically gliomas, is comprehensively elucidated. The possible correlation of ATRX status with other genetic/epigenetic modifications is also presented. We conclude by discussing some of the challenges associated with incorporating ATRX status assessment into routine clinical practice while also exploring opportunities for future diagnostics/therapeutics in gliomas based on ATRX status.
Keywords: ATRX; IDH; astrocytoma; glioma; oligodendroglioma.
Figures
Similar articles
-
[Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors. German version].Pathologe. 2019 Mar;40(2):131-139. doi: 10.1007/s00292-019-0575-6. Pathologe. 2019. PMID: 30790013 Review. German.
-
Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.Pathologe. 2019 Jun;40(Suppl 1):9-17. doi: 10.1007/s00292-019-0581-8. Pathologe. 2019. PMID: 31025086 Review. English.
-
IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.Oncotarget. 2015 Oct 6;6(30):30295-305. doi: 10.18632/oncotarget.4497. Oncotarget. 2015. PMID: 26210286 Free PMC article.
-
ATRX immunohistochemistry can help refine 'not elsewhere classified' categorisation for grade II/III gliomas.Br J Neurosurg. 2019 Oct;33(5):536-540. doi: 10.1080/02688697.2019.1600657. Epub 2019 Apr 24. Br J Neurosurg. 2019. PMID: 31018710
-
DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.Clin Epigenetics. 2017 Apr 4;9:32. doi: 10.1186/s13148-017-0331-9. eCollection 2017. Clin Epigenetics. 2017. PMID: 28392842 Free PMC article.
Cited by
-
Completely non-invasive prediction of IDH mutation status based on preoperative native CT images.Sci Rep. 2024 Nov 5;14(1):26763. doi: 10.1038/s41598-024-77789-6. Sci Rep. 2024. PMID: 39501053 Free PMC article.
-
Mutant ATRX: pathogenesis of ATRX syndrome and cancer.Front Mol Biosci. 2024 Oct 16;11:1434398. doi: 10.3389/fmolb.2024.1434398. eCollection 2024. Front Mol Biosci. 2024. PMID: 39479502 Free PMC article. Review.
-
Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.Int J Mol Sci. 2024 Jul 21;25(14):7974. doi: 10.3390/ijms25147974. Int J Mol Sci. 2024. PMID: 39063215 Free PMC article. Review.
-
A Synopsis of Biomarkers in Glioblastoma: Past and Present.Curr Issues Mol Biol. 2024 Jul 3;46(7):6903-6939. doi: 10.3390/cimb46070412. Curr Issues Mol Biol. 2024. PMID: 39057054 Free PMC article. Review.
-
Biomarker identification by interpretable maximum mean discrepancy.Bioinformatics. 2024 Jun 28;40(Suppl 1):i501-i510. doi: 10.1093/bioinformatics/btae251. Bioinformatics. 2024. PMID: 38940158 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous